Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Petros Pharmaceuticals Inc (NQ: PTPI ) 0.3301 -0.0049 (-1.46%) Streaming Delayed Price Updated: 3:30 PM EDT, Sep 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 50,867 Open 0.3300 Bid (Size) 0.3154 (5) Ask (Size) 0.3353 (27) Prev. Close 0.3350 Today's Range 0.3203 - 0.3400 52wk Range 0.2821 - 2.505 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 03, 2024 Via ACCESSWIRE PTPI Stock Earnings: Petros Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 August 16, 2024 PTPI stock results show that Petros Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD -76.75% -76.75% 1 Month -7.74% -7.74% 3 Month -33.85% -33.85% 6 Month -77.99% -77.99% 1 Year -86.13% -86.13% More News Read More Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) July 29, 2024 Via ACCESSWIRE Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance July 16, 2024 Via ACCESSWIRE EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says June 17, 2024 Via Benzinga Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA May 21, 2024 Via ACCESSWIRE Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil) April 16, 2024 Via ACCESSWIRE Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 13, 2024 Via Benzinga Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket June 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 13, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday June 13, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session May 29, 2024 Via Benzinga Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch May 29, 2024 Via ACCESSWIRE PTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 May 16, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's After-Market Session May 15, 2024 Via Benzinga Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals May 14, 2024 From 23andMe, Inc. Via GlobeNewswire Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe May 14, 2024 Via ACCESSWIRE Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health April 23, 2024 Via ACCESSWIRE Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 02, 2024 Via Benzinga PTPI Stock Earnings: Petros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 April 02, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 02, 2024 Via Benzinga Petros Pharmaceuticals Reports Positive Results in an Initial Cohort Two-Arm Self-Selection (Phase 2-Equivalent) Study for STENDRA(R) (avanafil) as it Pursues OTC Status April 02, 2024 Via ACCESSWIRE Petros Pharmaceuticals Successfully Launches AI Tool In Collaboration with Multi-Billion-Dollar Software Provider March 19, 2024 Via ACCESSWIRE BestGrowthStocks.Com Issues Comprehensive Analysis of Petros Pharmaceuticals Inc March 11, 2024 Via TheNewswire.com Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
